Lipella Pharmaceuticals Inc Asset Turnover Ratio (LIPO), as of third quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Lipella Pharmaceuticals Inc   (LIPO)
 

Lipella Pharmaceuticals Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Sep 30 2025, Lipella Pharmaceuticals Inc has not recorded any assets.
Visit Lipella Pharmaceuticals Inc Balance sheet

Within sector Lipella Pharmaceuticals Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2025 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LIPO Asset Turnover Ratio (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter		 (Dec 31 2024)
IV. Quarter		 (Sep 30 2024)
III. Quarter
Y / Y Asset Change 8.78 % 70.33 % 54.79 % -25.25 % -23.97 %
Y / Y Revenue Change - -36.43 % -11.3 % 43.71 % -22.75 %
Asset Turnover Ratio (TTM) - 0.14 0.18 0.21 0.17
LIPO's Total Ranking # # # # #
Seq. Asset Change -36.84 % -23.39 % 81.62 % 23.78 % -1.1 %
Seq. Revenue Change - -32.97 % -25.49 % 116.06 % -41.08 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




LIPO Company Profile • Back to LIPO Efficiency Comparisons • Compare LIPO Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2025 Assets at quarter ending Sep 30 2025
Cvrx inc   0.46 $ 56.286  Millions$ 123.473  Millions
Rxsight Inc   0.45 $ 141.534  Millions$ 312.287  Millions
Amphastar Pharmaceuticals Inc   0.45 $ 725.143  Millions$ 1,621.325  Millions
Foxo Technologies Inc   0.45 $ 20.704  Millions$ 46.425  Millions
Sonida Senior Living Inc   0.45 $ 375.417  Millions$ 842.748  Millions
Plus Therapeutics Inc   0.44 $ 5.258  Millions$ 11.927  Millions
Abbvie Inc   0.44 $ 59,644.000  Millions$ 135,601.500  Millions
Brightspring Health Services Inc   0.44 $ 2,613.128  Millions$ 5,941.545  Millions
Monte Rosa Therapeutics Inc   0.44 $ 181.538  Millions$ 412.840  Millions
Quidelortho Corp  0.44 $ 2,714.400  Millions$ 6,234.850  Millions
Invivyd Inc   0.43 $ 50.039  Millions$ 115.389  Millions
Perrigo Company Plc  0.43 $ 4,281.000  Millions$ 9,896.400  Millions
Teleflex Incorporated  0.43 $ 3,189.081  Millions$ 7,377.091  Millions
Ispecimen inc   0.43 $ 3.353  Millions$ 7.806  Millions
Integra Lifesciences Holdings Corp  0.43 $ 1,642.966  Millions$ 3,851.133  Millions
Teva Pharmaceutical Industries Limited  0.43 $ 16,778.000  Millions$ 39,432.000  Millions
Anaptysbio Inc   0.43 $ 169.467  Millions$ 398.559  Millions
Edwards Lifesciences Corporation  0.42 $ 5,599.100  Millions$ 13,209.625  Millions
Biomarin Pharmaceutical Inc  0.42 $ 3,094.001  Millions$ 7,301.789  Millions
Lemaitre Vascular Inc   0.42 $ 240.939  Millions$ 570.871  Millions
Outset Medical Inc   0.42 $ 120.270  Millions$ 285.766  Millions
Rhythm Pharmaceuticals Inc   0.42 $ 174.334  Millions$ 414.641  Millions
Ars Pharmaceuticals Inc   0.42 $ 142.772  Millions$ 341.187  Millions
Surgery Partners Inc   0.41 $ 3,288.100  Millions$ 7,935.150  Millions
United Therapeutics Corporation  0.41 $ 3,128.400  Millions$ 7,591.750  Millions
Anika Therapeutics Inc   0.41 $ 79.338  Millions$ 192.616  Millions
Urogen Pharma Ltd   0.41 $ 95.358  Millions$ 231.773  Millions
Inmed Pharmaceuticals Inc  0.41 $ 4.798  Millions$ 11.681  Millions
Amgen Inc   0.40 $ 35,971.000  Millions$ 89,811.000  Millions
Cytek Biosciences Inc   0.40 $ 196.962  Millions$ 492.584  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.